Romano Brothers & Co’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25M Sell
50,208
-1,100
-2% -$88.7K 0.43% 71
2026
Q1
$3.63M Sell
51,308
-50
-0.1% -$3.74K 0.41% 73
2025
Q4
$4.05M Sell
51,358
-466
-0.9% -$36.9K 0.46% 65
2025
Q3
$4.27M Buy
51,824
+1,460
+3% +$115K 0.49% 60
2025
Q2
$4.05M Sell
50,364
-2,237
-4% -$173K 0.5% 58
2025
Q1
$4.22M Sell
52,601
-1,383
-3% -$115K 0.55% 55
2024
Q4
$4.42M Sell
53,984
-530
-1% -$44.1K 0.56% 51
2024
Q3
$4.5M Buy
54,514
+1,727
+3% +$129K 0.56% 55
2024
Q2
$3.71M Sell
52,787
-2,315
-4% -$165K 0.51% 55
2024
Q1
$4.08M Sell
55,102
-645
-1% -$45K 0.56% 57
2023
Q4
$3.69M Sell
55,747
-937
-2% -$58.6K 0.55% 54
2023
Q3
$3.57M Buy
56,684
+225
+0.4% +$14K 0.55% 54
2023
Q2
$3.19M Sell
56,459
-550
-1% -$30.5K 0.48% 68
2023
Q1
$3.3M Sell
57,009
-620
-1% -$41.8K 0.51% 66
2022
Q4
$4.17M Buy
57,629
+658
+1% +$47.1K 0.63% 50
2022
Q3
$3.47M Buy
+56,971
New +$3.64M 0.56% 57

Other funds holding MET

Romano Brothers & Co's MET Position: Q2 2026 in Review

Romano Brothers & Co reduced its MetLife (MET) stake by 2.1% in Q2 2026, selling an estimated $88.7K and leaving 50,208 shares worth $4.25M. The position accounts for 0.43% of the portfolio, ranked #71.

Romano Brothers & Co first reported a position in MET in Q3 2022 and has held it in 16 quarters since. The position peaked at $4.5M in Q3 2024. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Romano Brothers & Co held 50,208 shares of MetLife worth $4.25M as of Q2 2026.
  • Romano Brothers & Co sold 1,100 MetLife shares in Q2 2026, an estimated $88.7K.
  • MetLife made up 0.43% of Romano Brothers & Co's portfolio in Q2 2026, its #71 holding.
  • Romano Brothers & Co first reported a position in MetLife in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's MetLife position peaked at $4.5M in Q3 2024.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.